Life Sciences · Colombia & Latin America

Transforming complexity into confident decisions.

OWLEN integrates science, regulation, quality, operations and business judgment to help pharmaceutical and life sciences companies evaluate the right path into Colombia and Latin America.

iPHEX 2026

For international manufacturers, dossier owners and partners exploring regulatory, market-entry, licensing or commercial opportunities in Colombia and Latin America.

From technical complexity to a confident next step.

OWLEN is not a generic regulatory filing office. We connect scientific, regulatory, quality and business implications so decisions are evaluated in context—not as disconnected workstreams.

01

Regulatory Affairs

Regulatory strategy, dossier readiness, submissions and lifecycle management.

02

Market Access

Market-entry implications, access considerations and decision support.

03

Quality & GMP

Quality readiness, GMP requirements, compliance and operational support.

04

CMC & Technical Strategy

Technical evidence, CMC dependencies and risk-informed planning.

05

Due Diligence

Regulatory, technical and commercial review before investment or partnership decisions.

06

Business Development & Commercial Partnerships

Licensing, partner identification and local commercialization pathways.

Considering Colombia?

Evaluate regulatory pathway, dossier readiness, market access, quality requirements, local operating model and partnership options before committing resources.

Continue the conversation